Atlassian (NASDAQ:TEAM) Director Sells $1,192,520.70 in Stock

Atlassian Corporation PLC (NASDAQ:TEAM) Director Scott Farquhar sold 7,665 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of $155.58, for a total transaction of $1,192,520.70. Following the transaction, the director owned 275,940 shares in the company, valued at $42,930,745.20. This trade represents a 2.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Scott Farquhar also recently made the following trade(s):

• On Monday, November 10th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $158.00, for a total transaction of $1,211,070.00.
• On Wednesday, November 5th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $162.66, for a total transaction of $1,246,788.90.
• On Monday, November 3rd, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $172.79, for a total value of $1,324,435.35.
• On Friday, October 31st, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $167.61, for a total value of $1,284,730.65.
• On Wednesday, October 29th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $160.41, for a total value of $1,229,542.65.
• On Monday, October 27th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $165.03, for a total value of $1,264,954.95.
• On Friday, October 24th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $164.50, for a total transaction of $1,260,892.50.
• On Wednesday, October 22nd, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $169.16, for a total transaction of $1,296,611.40.
• On Friday, October 17th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $151.21, for a total transaction of $1,159,024.65.
• On Monday, October 20th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $157.28, for a total transaction of $1,205,551.20.

Atlassian Stock Down 1.3%

NASDAQ:TEAM opened at $155.50 on Thursday. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 0.72. The stock has a 50 day moving average of $162.26 and a 200-day moving average of $185.23. The firm has a market capitalization of $40.91 billion, a PE ratio of -219.01, a price-to-earnings-growth ratio of 37.36 and a beta of 0.95. Atlassian Corporation PLC has a 52 week low of $144.32 and a 52 week high of $326.00.

Atlassian (NASDAQ:TEAM) last released its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.21. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. The business’s revenue for the quarter was up 20.6% compared to the same quarter last year. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Institutional Trading of Atlassian

A number of large investors have recently added to or reduced their stakes in the business. State of Wyoming increased its holdings in shares of Atlassian by 20.3% in the first quarter. State of Wyoming now owns 278 shares of the technology company’s stock valued at $59,000 after buying an additional 47 shares in the last quarter. Physician Wealth Advisors Inc. grew its holdings in shares of Atlassian by 60.4% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock worth $26,000 after acquiring an additional 61 shares during the last quarter. EP Wealth Advisors LLC raised its position in shares of Atlassian by 2.8% during the first quarter. EP Wealth Advisors LLC now owns 2,641 shares of the technology company’s stock worth $561,000 after purchasing an additional 71 shares during the period. Snowden Capital Advisors LLC raised its position in shares of Atlassian by 1.6% during the second quarter. Snowden Capital Advisors LLC now owns 4,464 shares of the technology company’s stock worth $907,000 after purchasing an additional 71 shares during the period. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Atlassian by 11.5% during the first quarter. Smartleaf Asset Management LLC now owns 716 shares of the technology company’s stock valued at $156,000 after purchasing an additional 74 shares during the last quarter. 94.45% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on TEAM shares. KeyCorp dropped their price objective on shares of Atlassian from $250.00 to $210.00 and set an “overweight” rating on the stock in a report on Thursday, October 23rd. Raymond James Financial reduced their price objective on Atlassian from $300.00 to $250.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Macquarie decreased their price objective on Atlassian from $250.00 to $240.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Cowen reaffirmed a “hold” rating on shares of Atlassian in a research note on Monday, October 27th. Finally, BMO Capital Markets boosted their price target on Atlassian from $190.00 to $195.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Atlassian has a consensus rating of “Moderate Buy” and a consensus target price of $239.44.

Atlassian Company Profile

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.